Advanced search
Publication Cover
Current Medical Research and Opinion Volume 37, 2021 - Issue 5
Submit an article Journal homepage
223
Views
7
CrossRef citations to date
0
Altmetric
Oncology

Impact of body mass index on survival and serious adverse events in advanced non-small cell lung cancer treated with bevacizumab: a meta-analysis of randomized clinical trials

Soham Shuklaa Center for Health Economics and Outcomes Research, The State University of New Jersey, Rutgers, NJ, USAORCID Iconhttps://orcid.org/0000-0002-4139-0856
ORCID Icon,
Zachary Babcocka Center for Health Economics and Outcomes Research, The State University of New Jersey, Rutgers, NJ, USA
,
Laura Pizzia Center for Health Economics and Outcomes Research, The State University of New Jersey, Rutgers, NJ, USA
&
Luigi Brunettib Pharmacy Practice and Administration, Ernest Mario School of Pharmacy, The State University of New Jersey, Rutgers, NJ, USA;c Center of Excellence in Pharmaceutical Translational Research and Education, Ernest Mario School of Pharmacy, The State University of New Jersey, Rutgers, NJ, USACorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-0565-6167
ORCID Icon
Pages 811-817 | Received 27 Oct 2020, Accepted 04 Mar 2021, Published online: 24 Mar 2021

Citations (7)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Yi Wang, Lei Luo, Ji Li, Yan Wang, Guowei Che & Xiaoyang Xie. (2022) Prognostic Value of Pretreatment Geriatric Nutrition Risk Index in Lung Cancer Patients: A Meta-Analysis. Nutrition and Cancer 74:9, pages 3164-3171.
Read now

Articles from other publishers (6)

H. Wen, G. Deng, X. Shi, Z. Liu, A. Lin, Q. Cheng, J. Zhang & P. Luo. (2024) Body mass index, weight change, and cancer prognosis: a meta-analysis and systematic review of 73 cohort studies. ESMO Open 9:3, pages 102241.
Crossref
Jakub Krzysztof Gałązka, Marcin Czeczelewski, Tomasz Kucharczyk, Katarzyna Szklener & Sławomir Mańdziuk. (2024) Obesity and lung cancer – is programmed death ligand-1 (PD-1L) expression a connection?. Archives of Medical Science 20:1, pages 313-316.
Crossref
Mathew Vithayathil, Antonio D’Alessio, Claudia Angela Maria Fulgenzi, Naoshi Nishida, Martin Schönlein, Johann von Felden, Kornelius Schulze, Henning Wege, Anwaar Saeed, Brooke Wietharn, Hannah Hildebrand, Linda Wu, Celina Ang, Thomas U. Marron, Arndt Weinmann, Peter R. Galle, Dominik Bettinger, Bertram Bengsch, Arndt Vogel, Lorenz Balcar, Bernhard Scheiner, Pei-Chang Lee, Yi-Hsiang Huang, Suneetha Amara, Mahvish Muzaffar, Abdul Rafeh Naqash, Antonella Cammarota, Valentina Zanuso, Tiziana Pressiani, Matthias Pinter, Alessio Cortellini, Masatoshi Kudo, Lorenza Rimassa, David J. Pinato & Rohini Sharma. (2023) Impact of body mass index in patients receiving atezolizumab plus bevacizumab for hepatocellular carcinoma. Hepatology International.
Crossref
Jingyuan Wang, Joshua Millstein, Yan Yang, Sebastian Stintzing, Hiroyuki Arai, Francesca Battaglin, Natsuko Kawanishi, Shivani Soni, Wu Zhang, Christoph Mancao, Chiara Cremolini, Tianshu Liu, Volker Heinemann, Alfredo Falcone, Lin Shen & Heinz-Josef Lenz. (2023) Impact of genetic variants involved in the lipid metabolism pathway on progression free survival in patients receiving bevacizumab-based chemotherapy in metastatic colorectal cancer: a retrospective analysis of FIRE-3 and MAVERICC trials. eClinicalMedicine 57, pages 101827.
Crossref
Jia Xiang, Mengyao Ding, Jixing Lin, Tianhui Xue, Qianwen Ye & Bing Yan. (2022) Preoperative carcinoembryonic antigen to body mass index ratio contributes to prognosis prediction in colorectal cancer. Oncology Letters 24:5.
Crossref
Anning Xiong, Wei Nie, Lei Cheng, Hua Zhong, Tianqing Chu, Runbo Zhong, Jun Lu, Shuyuan Wang, Jianlin Xu, Yinchen Shen, Feng Pan, Baohui Han & Xueyan Zhang. (2022) Association Between Obesity and Poor Prognosis in Patients Receiving Anlotinib for Advanced Non-Small Cell Lung Cancer. Frontiers in Pharmacology 13.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.